PACS Group Boosts 2026 Outlook as 1Q Tops Views

Dow Jones
05/12
 

By Adriano Marchese

 

Shares in PACS Group rose in premarket trading Tuesday after raising its full-year earnings outlook following a stronger-than-expected first quarter.

Shares rose 18% in premarket trading to C$37.50.

The healthcare company late Monday said it now expects adjusted earnings before interest, taxes, depreciation and amortization of between $605 million and $625 million, up from a previous guidance of $555 million to $575 million.

Analysts polled on FactSet expected $567.2 million.

At the midpoint, the new guidance represents a 22% growth over 2025.

Revenue guidance is maintained at $5.65 billion to $5.75 billion.

PACS noted that the guidance doesn't include any future acquisition, but Chief Executive Carey Hendrickson said that the company has a healthy pipeline of acquisition opportunities that it is actively considering.

For the first quarter, revenue rose 11% to $1.42 billion, topping Wall Street expectations of C$1.36 billion, according to FactSet.

Net income rose to C$80.7 million from C$28.4 million a year earlier, which on a per-share basis was a rise to 50 cents from 17 cents.

Analysts were expecting 40 cents a share.

Hendrickson credits the quarter's results to a strong performance from both newer and existing facilities, as well as improving patient mix.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

May 12, 2026 08:47 ET (12:47 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10